Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochemistry
2009 Dec 22;4850:11872-82. doi: 10.1021/bi9014488.
Show Gene links
Show Anatomy links
Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
Balannik V
,
Wang J
,
Ohigashi Y
,
Jing X
,
Magavern E
,
Lamb RA
,
Degrado WF
,
Pinto LH
.
???displayArticle.abstract???
The A/M2 proton channel of influenza A virus is a target for the anti-influenza drugs amantadine and rimantadine, whose effectiveness was diminished by the appearance of naturally occurring point mutants in the A/M2 channel pore, among which the most common are S31N, V27A, and L26F. We have synthesized and characterized the properties of a series of compounds, originally derived from the A/M2 inhibitor BL-1743. A lead compound emerging from these investigations, spiro[5.5]undecan-3-amine, is an effective inhibitor of wild-type A/M2 channels and L26F and V27A mutant ion channels in vitro and also inhibits replication of recombinant mutant viruses bearing these mutations in plaque reduction assays. Differences in the inhibition kinetics between BL-1743, known to bind inside the A/M2 channel pore, and amantadine were exploited to demonstrate competition between these compounds, consistent with the conclusion that amantadine binds inside the channel pore. Inhibition by all of these compounds was shown to be voltage-independent, suggesting that their charged groups are within the N-terminal half of the pore, prior to the selectivity filter that defines the region over which the transmembrane potential occurs. These findings not only help to define the location and mechanism of binding of M2 channel-blocking drugs but also demonstrate the feasibility of discovering new inhibitors that target this binding site in a number of amantadine-resistant mutants.
Balannik,
The oligomeric state of the active BM2 ion channel protein of influenza B virus.
2008, Pubmed
Balannik,
The oligomeric state of the active BM2 ion channel protein of influenza B virus.
2008,
Pubmed
Bright,
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
2006,
Pubmed
Bright,
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.
2005,
Pubmed
Cady,
Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding.
2009,
Pubmed
Chen,
Proton transport behavior through the influenza A M2 channel: insights from molecular simulation.
2007,
Pubmed
Cox,
Influenza.
1999,
Pubmed
Deyde,
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
2007,
Pubmed
Duff,
Neutron diffraction reveals the site of amantadine blockade in the influenza A M2 ion channel.
1994,
Pubmed
Furuse,
Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.
2009,
Pubmed
Gandhi,
Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein.
1999,
Pubmed
,
Xenbase
Garten,
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.
2009,
Pubmed
Hay,
The molecular basis of the specific anti-influenza action of amantadine.
1985,
Pubmed
Hu,
Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity.
2006,
Pubmed
Hu,
Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus.
2007,
Pubmed
Jing,
Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
2008,
Pubmed
,
Xenbase
Khurana,
Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus.
2009,
Pubmed
Lagoja,
Anti-influenza virus agents: synthesis and mode of action.
2008,
Pubmed
Li,
Solid-state NMR and MD simulations of the antiviral drug amantadine solubilized in DMPC bilayers.
2008,
Pubmed
Li,
In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cells.
2009,
Pubmed
Pielak,
Mechanism of drug inhibition and drug resistance of influenza A M2 channel.
2009,
Pubmed
Pinto,
Controlling influenza virus replication by inhibiting its proton channel.
2007,
Pubmed
Pinto,
The M2 proton channels of influenza A and B viruses.
2006,
Pubmed
Pinto,
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity.
1997,
Pubmed
,
Xenbase
Saito,
Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2.
2003,
Pubmed
Schnell,
Structure and mechanism of the M2 proton channel of influenza A virus.
2008,
Pubmed
Shimbo,
Ion selectivity and activation of the M2 ion channel of influenza virus.
1996,
Pubmed
,
Xenbase
Stouffer,
The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus.
2008,
Pubmed
,
Xenbase
Stouffer,
Sequence determinants of a transmembrane proton channel: an inverse relationship between stability and function.
2005,
Pubmed
Stouffer,
Structural basis for the function and inhibition of an influenza virus proton channel.
2008,
Pubmed
Takeda,
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
2002,
Pubmed
Tu,
Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
1996,
Pubmed
,
Xenbase
Wang,
Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus.
2009,
Pubmed
,
Xenbase
Wang,
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
1993,
Pubmed
,
Xenbase
Yi,
A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine.
2008,
Pubmed
